Cardiovascular risk and benefits from antioxidant dietary intervention with red wine in asymptomatic hypercholesterolemics

Clinical Nutrition ESPEN

Volumn 10, Issue 6, 2015, Pages e224-e233

  Apostolidou, C ^a,b   Adamopoulos, K ^a   Lymperaki, E ^c   Iliadis, S ^a   Papapreponis, P ^d   Kourtidou Papadeli, C ^e  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b General Chemical State Laboratory   (Greece)

^c ALEXANDER TECHNOLOGICAL EDUCATIONAL INSTITUTE OF THESSALONIKI   (Greece)

^d Theageneio Cancer Hospital   (Greece)

^e Aeromedical Center of Thessaloniki (AeMC)   (Greece)

Author keywords

Asymptomatic hypercholesterolemia; Cardiovascular risk; Low density lipoprotein to high density lipoprotein cholesterol ratio(LDL HDL); Red wine polyphenol content (RWPC); Total antioxidant capacity (TAC); Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BIOLOGICAL MARKER; CHOLESTEROL;

ADULT; AGED; ASYMPTOMATIC DISEASE; BLOOD; CARDIOVASCULAR DISEASE; COMPLICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; FEMALE; GREECE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PROTECTION; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; WINE; YOUNG ADULT;

ADULT; AGED; ANTIOXIDANTS; ASYMPTOMATIC DISEASES; BIOMARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL; FEMALE; GREECE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; PROTECTIVE FACTORS; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VITAMIN E; WINE; YOUNG ADULT;

EID: 84957808816     PISSN: 24054577     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnesp.2015.08.001     Document Type: Article

References (43)

1. Juhola J., Magnussen C.G., Viikari J.S.A., Kähönen M., Hutri-Kähönen N., Jula A., et al. Tracking of serum lipid levels, blood pressure, and body mass index from childhood to adulthood: the cardiovascular risk in Young Finns Study. J Pediatr 2011, 159:584-590.
2. Renaud S., De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339:1523-1526.
3. Gaziano J.M., Buring J.E., Breslow J.L., Goldhaber S.Z., Rosner B., VanDenburgh M., et al. Moderate alcohol intake, increased levels of high-densitylipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 1993, 329:1829-1834.
4. Lassaletta A.D., Chu L.M., Elmadhun N.Y., Burgess T.A., Feng J., Robich M.P., et al. Cardioprotective effects of red wine and vodka in a model of endothelial dysfunction. J Surg Res 2012, 178(2):586-592.
5. Perez-Vizcaino F., Duarte J., Jimenez R., Santos-Buelga C., Osuna A. Antihypertensive effects of the flavonoid quercetin. Pharmacol Rep 2009, 61:67-75.
6. Zenebe W., Pechánová O., Bernátová I. Protective effects of red wine polyphenolic compounds on the cardiovascular system review. Exp Clin Cardiol 2001, 6(3):153-158. autumn.
7. Quinones M., Miguel M., Aleixandrea A. Review: beneficial effects of polyphenols on cardiovascular disease. Pharmacol Res 2013, 68:125-131.
8. Zern Tosca L., Fernandez Maria Luz Cardioprotective effects of dietary polyphenols. J Nutr October 1, 2005, 135(10):2291-2294.
9. Harrison D., Griendling K.K., Landmesser U., Hornig B., Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003, 91:7A-11A.
10. Miller N., Rice-Evans C., Davies M.J. A novel method for measuring antioxidant capacity and its application to monitoring the antioxidant status in premature neonates. Clin Sci 1993, 84:407-412.
11. Roerecke M., Rehm J. Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis. Heart 2014, published online Aug 6, eCollection 2014. 10.1136/openhrt-2014-000135.
12. Sato M., Ramarathnam N., Suzuki Y., Ohkubo T., Takeuchi M., Ochi H. Varietal differences in the phenolic content and superoxide radical scavenging potential of wine from different sources. J Agric Food Chem 1996, 44:37-41.
13. Boido E., Garcia-Marino M., Dellacassa E., Carrau F., Rivas-Gonzalo C.J., Escribano-597 Bailon T.M. Characterization and evolution of grape polyphenol profiles of VitisviniferaL. Tannat during ripening and vinification. Aust J Grape Wine Res 2011, 17(3):383-393.
14. Ross C.F., Weller K. Development of a low-alcohol drink similar in sensory properties to a full-alcohol drink. J Alcohol Drug Educ 2008, 52:37-45.
15. U.S Department of Agriculture U.S. Department of health and human services. Dietary guidelines for Americans 2010, U.S. Government Printing Office, Washington (DC), 2010 Dec. 99 pp.
16. Cordero A., Andres E., Ordonez B., Leon M., Laclaustra M., Grima A., et al. Metabolic syndrome active subjects study investigators. Usefulness of triglycerides-to-high-density lipoprotein cholesterol ratio for predicting the first coronary event in men. Am J Cardiol 2009, 104:1393-1397.
17. Onat A., Can G., Kaya H., Hergenc G. Atherogenic index of plasma (log10 triglyceride/high t density lipoprotein-cholesterol) predicts high blood pressure diabetes and vascular events. J ClinLipidol 2010, 4:89-98.
18. Baigent C., Keech A., Kearney P.M., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005, 366(9493):1267-1278.
19. Rice-Evans C.A. Measurement of total antioxidant activity as a marker of antioxidant status in vivo: procedures and limitations. Free Radic Res 2000, S59-S66. 33 Suppl.
20. Arnaud J., Fortis I., Blachier S., Favier K., Favier A. Simultaneous determination of retinol, a-tocopherol, and β-carotene in serum by isocratic high-performance liquid chromatography. J Chromatogr 1991, 572:103-111.
21. International Wine and Spirits Report 2010, . http://www.vinexpo.com/dyn/press/le-marche-hong-kong.
22. Guarda E., Godoy I., Foncea R., Perez D.D., Romero C., Venegas R., et al. Red wine reduces oxidative stress in patients with acute coronary syndrome. Int J Cardiol 2005, 104:35-38.
23. Behrenbeck T.R., McCollough C.H., Miller W.L., Williamson E.E., Leng S., Kline T.L., et al. Early changes in myocardial microcirculation in asymptomatic hypercholesterolemic subjects: as detected by perfusion CT. Ann Biomed Eng 2013, 42(3):515-525.
24. Cook N.C., Samman S. Flavonoids-Chemistry, metabolism, cardioprotective effects, and dietary sources. Nutr Biochem 1996, 7:66-76.
25. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. J Biol Chem 1997, 272:20963-20966.
26. Nigdikar S.V., Williams N.R., Griffin B.A., Howard A.N. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 1998, 68:258-265.
27. Gemma C.B., Arranz S., Lamuela-Raventos R.M., Estruch R. Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors. Alcohol 2013, 48(3):270-277.
28. Criqui M.H., Ringel B.L. Does diet or alcohol explain the French paradox?. Lancet 1994, 344:1719-1723.
29. Hertog M.G., Feskens E.J., Hollman P.C., Katan M.B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993, 342:1007-1011.
30. Lee R., Margaritis M., Channon K.M., Antoniades C. Evaluating oxidative stress in human cardiovascular disease: methodological aspects and considerations. Curr Med Chem 2012 Jun, 19(16):2504-2520.
31. Ghiselli A., Serafini M., Natella F., Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 2000, 29(11):1106-1114.
32. Berry E.M., Kohen R. Is the biological antioxidant system integrated and regulated?. Med Hypotheses 1999, 53(5):397-401.
33. Young I.S. Measurement of total antioxidant capacity. J Clin Pathol 2001, 54(5):339.
34. Duffy S.J., Keaney J.F., Holbrook M., Gokce N., Swerdloff P.L., Frei B., et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001, 104(2):151-156.
35. Steinberg D. Antioxidants in the prevention of human atherosclerosis. Summary of the proceedings of a national heart. Lung and blood Institute workshop: September 5-6, 1991, Bethesda, Maryland. Circulation 1992, 85:2337-2344.
36. Simon E., Paul J.L., Soni T., Simon A., Moatt N. Plasma and erythrocyte vitamin E content in asymptomatic hypercholesterolemic subjects. Clin Chem 1997, 43:285-289.
37. Urquiaga I., Strobe P., Perez D., Martinez C., Cuevas A., Castillo O., et al. Mediterranean diet and red wine protect against oxidative damage in young volunteers. Atherosclerosis 2010, 211(2):694-699.
38. AroraA Nair MG., Strasburg G.M. Structure activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic Biol Med 1998, 24:1355-1363.
39. Middleton E.J.R., Kandaswami C., Theoharides T.C. The effect of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol Rev 2000, 52:673-751.
40. Harats D., Chevion S., Nahir M., Norman Y., Sagee O., Berry E.M. Citrus fruit supplementation reduces lipoprotein oxidation in young men ingesting a diet high in saturated fat: presumptive evidence for an interaction between vitamin C and E in vivo. Am J Clin Nutr 1998, 67:240-245.
41. Glascott P.A., Farber J.L. Assessment of physiological interaction between vitamin E and vitamin C. Methods Enzymol 1999, 300:78-88.
42. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl J Med 1993, 328:1450-1456.
43. Mihaylova B., Emberson J., Blackwell L., Keech A., Simes J., Barnes E.H., et al. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomized trials. Lancet 2012, 380:581-590.